$BANKBARODA 's $600M Settlement in NMC Health Collapse

$BANKBARODA (BoB) has agreed to a $600 million (approximately ₹5,700 crore) out-of-court settlement with the joint administrators of NMC Health. This resolution ends the lender's involvement in one of the most prominent overseas litigation cases faced by an Indian state-run bank. Origin of the Dispute: The legal battle followed the 2020 collapse of the UAE-based healthcare giant after more than $4 billion in hidden debt was uncovered. Administrators alleged that BoB's Abu Dhabi branch processed transactions that concealed NMC's true financial health and failed to perform adequate anti-money laundering and due diligence checks. A Sudden Strategic Pivot: The settlement represents a major shift from BoB’s position in its FY26 annual report, where the bank claimed to have a robust legal defense and therefore made no financial provisions. The deal was struck right after the trial concluded in the Abu Dhabi Global Market (ADGM) courts but before a formal judgment could be rendered. Impact on Profitability: Representing nearly 28% of the bank's FY26 net profit of ₹20,021 crore, this one-time payout will heavily weigh on BoB's earnings in the early quarters of FY27. However, market analysts maintain that the bank's long-term capital position, stability, and double-digit growth prospects remain intact. Reignited Collusion Fraud Allegations: Although BoB settled without admitting any liability or wrongdoing, the decision has revived public accusations by NMC founder B.R. Shetty. Shetty alleges that senior bank officials actively colluded with former company executives to facilitate fund siphoning, evergreen loans, and forgery.